首页> 美国卫生研究院文献>International Journal of Methods in Psychiatric Research >Clinical reappraisal of the Composite International Diagnostic Interview Screening Scales (CIDI-SC) in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)
【2h】

Clinical reappraisal of the Composite International Diagnostic Interview Screening Scales (CIDI-SC) in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)

机译:陆军研究中综合国际诊断面试综合量表(CIDI-SC)的临床评估以评估服务人员的风险和应变能力(陆军STARRS)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A clinical reappraisal study was carried out in conjunction with the Army STARRS All-Army Study (AAS) to evaluate concordance of DSM-IV diagnoses based on the Composite International Diagnostic Interview screening scales (CIDI-SC) and PTSD Checklist (PCL) with diagnoses based on independent clinical reappraisal interviews (Structured Clinical Interview for DSM-IV [SCID]). Diagnoses included: lifetime mania/hypomania, panic disorder, and intermittent explosive disorder; 6-month adult attention-deficit/hyperactivity disorder; and 30-day major depressive episode, generalized anxiety disorder, PTSD, and substance (alcohol or drug) use disorder (abuse or dependence). The sample (n=460) was weighted for over-sampling CIDI-SC/PCL screened positives. Diagnostic thresholds were set to equalize false positives and false negatives. Good individual-level concordance was found between CIDI-SC/PCL and SCID diagnoses at these thresholds (AUC = .69–.79). AUC was considerably higher for continuous than dichotomous screening scale scores (AUC = .80–.90), arguing for substantive analyses using not only dichotomous case designations but also continuous measures of predicted probabilities of clinical diagnoses.
机译:与陆军STARRS全军研究(AAS)一起进行了临床重新评估研究,以基于综合国际诊断面试筛选量表(CIDI-SC)和PTSD检查表(PCL)评估DSM-IV诊断的一致性基于独立的临床重新评估访谈(DSM-IV [SCID]的结构化临床访谈)。诊断包括:一生躁狂症/低躁狂症,惊恐症和间歇性爆发性疾病; 6个月的成年人注意力不足/多动症;和30天的重度抑郁发作,广泛性焦虑症,PTSD和物质(酒精或药物)使用障碍(滥用或依赖性)。对样品(n = 460)进行加权以对CIDI-SC / PCL筛选的阳性样品进行过采样。诊断阈值设置为使假阳性和假阴性相等。在这些阈值下,CIDI-SC / PCL和SCID诊断之间发现了良好的个体水平一致性(AUC = .69–.79)。连续的AUC显着高于二分法筛查量表评分(AUC = .80–.90),这表明不仅要进行二分法病例分配,而且要对临床诊断的预测概率进行连续测量,以进行实质性分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号